27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Claire Stawnyczy, CEO of Lophos Pharmaceuticals (CSE:MESC), was a guest recently on Benzinga’s All-Access.
Lophos Pharmaceuticals is a bioscience company involved in the research and development of mescaline and peyote medicines for indications from mental health to alcohol use disorder. The company is also the largest producer of peyote in Canada, having developed a process that shrinks the cultivation time from 13 years in the wild to 3 years.
Lophos just received their CSDL from Health Canada.
Learn more here:
Featured photo by Christopher Cassidy on Unsplash.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!